MYC promotes group 3 medulloblastoma cell proliferation and alleviates ROS-induced cell death by upregulating transketolase
Abstract Medulloblastoma is a common embryonic malignant tumor in children. Patients with Group 3 medulloblastoma exhibit the poorest prognosis among all subgroups, and approximately 20% of these patients carry an amplification of MYC. Metabolic reprogramming, a hallmark of cancer, includes the pent...
Saved in:
| Main Authors: | Shizun Wang, Dan Zhang, Chunlong Wang, Yuqin Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-06-01
|
| Series: | Acta Neuropathologica Communications |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40478-025-02051-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of transketolase in the immunotherapy and prognosis of hepatocellular carcinoma: a multi-omics approach
by: Xuan-Yu Gu, et al.
Published: (2025-03-01) -
The potential of ribonucleotide reductase M2 as a novel prognostic maker and therapeutic target to inhibit medulloblastoma proliferation, migration, and invasiveness
by: Xuanxuan Wu, et al.
Published: (2024-09-01) -
HJURP modulates cell proliferation and chemoresistance via the MYC/TOP2A transcriptional axis in gastric cancer
by: Xu Li, et al.
Published: (2025-04-01) -
Modulation of Stemness and Differentiation Regulators by Valproic Acid in Medulloblastoma Neurospheres
by: Natália Hogetop Freire, et al.
Published: (2025-01-01) -
Oxidative stress enhances the therapeutic action of a respiratory inhibitor in MYC‐driven lymphoma
by: Giulio Donati, et al.
Published: (2023-05-01)